• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number NX1000-1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Air Embolism (1697); Cardiac Arrest (1762); Stroke/CVA (1770); Death (1802); Seizures (2063); Dizziness (2194); Brain Injury (2219)
Event Date 04/03/2020
Event Type  Death  
Manufacturer Narrative
A review of the device history record (dhr) was conducted which confirmed that the product met all quality criteria and manufacturing specifications prior to release.(b)(4).
 
Event Description
A report was received on 24 apr 2020 from the home therapy nurse (htn) regarding a (b)(6) year old female with an extensive medical history who became dizzy and unresponsive after troubleshooting alarms and terminating hemodialysis treatment with rinseback on (b)(6) 2020.911 was called and the patient was transported to hospital where she subsequently expired on (b)(6) 2020.Additional information was received 29 apr 2020 from the htn which showed resuscitation measures included intubation and epinephrine (route not specified).After arriving at the hospital the patient was admitted to the intensive care unit (icu).A ct scan revealed an air embolism in the brain.The hospital course involved the patient being mechanically ventilated for acute respiratory failure secondary to the anoxic brain injury and an acute bifrontal lobe embolic cerebrovascular accident (cva).The patient remained unresponsive and areflexic and was given a poor prognosis.Their condition worsened due to systemic inflammatory response syndrome, brain injury, acute encephalopathy and seizures.The patient was extubated on (b)(6) 2020, placed on comfort care and expired at 21:45hrs on (b)(6) 2020 with cardiac arrest reported as the cause of death.
 
Manufacturer Narrative
The device was received and evaluated and was found to be functioning as designed and intended.The log file for the treatment was analyzed and findings showed that at the time of the event the prime and alarm test was still in progress.During the prime and alarms test some safety systems, including air alarms, are inactive to allow the user to expel air from the extracorporeal circuit.The nxstage system one user guide warns to never connect the patient to the cartridge before you see the treatment parameters in the nxstage system one cycler¿s window, which indicates that the prime and alarms test is completed.There was no device malfunction.The available information is consistent with a use error and the diagnosis of air embolism provided by the physician.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
MDR Report Key10083032
MDR Text Key191836464
Report Number3003464075-2020-00026
Device Sequence Number1
Product Code KDI
Combination Product (y/n)Y
PMA/PMN Number
K050525
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 01/01/2005,06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Device Operator Lay User/Patient
Device Model NumberNX1000-1
Device Catalogue NumberCYC-D2E W/ SERVICE COMPUTER
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/20/2020
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 04/24/2020
Initial Date FDA Received05/22/2020
Supplement Dates Manufacturer Received05/20/2020
Supplement Dates FDA Received06/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization;
Patient Age40 YR
Patient Weight56
-
-